Skip to main content
Previous
Poster Home
Next
Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018- 2021): A Review of Criticism and Concerns in Comments from Regulators
07:30am - 03:35pm EST - April 5, 2024
Information
Resources
Abstract: JNCCN23-0658
https://jnccn.org/view/journal...
Author(s):
Erin Comerford, MS
, Director, HEOR, Sanofi
Tags:
Outcomes and Health Services Research
Display Label
Action
025 - General Poster Session
Download Handout
Comerford E et al_NCCN Poster_Critical Comments PRO_FDA_v1.2_2024_02_29.pdf
Download Handout